Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing 1 - 25 of 1,590
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Medicine in People With Relapsed Refractory Multiple

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Sep 29, 2022

Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

Not yet recruiting
  • Cancer Prevention
  • +5 more
  • Prolonged Fasting Intervention
  • EDUCATION CONTROL
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 3, 2022

Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)

Not yet recruiting
  • Multiple Myeloma
  • Modakafusp alfa
  • +5 more
  • Little Rock, Arkansas
  • +38 more
Sep 29, 2022

Multiple Myeloma Trial (GPC-100, Propranolol, G-CSF)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Sep 29, 2022

Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • New York, New York
    Icahn School of Medicine
Sep 26, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma, Refractory Trial (Pomalidomide 4 mg every day in cycle 1,

Not yet recruiting
  • Multiple Myeloma in Relapse
  • +2 more
  • Pomalidomide 4 mg every day in cycle 1
  • +4 more
  • (no location specified)
Sep 26, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • La Jolla, California
  • +165 more
Sep 27, 2022

HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (BNT162b2, mRNA-1273, NVX-COV2373)

Not yet recruiting
  • HIV
  • +5 more
  • BNT162b2
  • +2 more
  • Melbourne, Victoria, Australia
    Alfred Health
Sep 25, 2022

Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia Trial in Birmingham

Recruiting
  • Multiple Myeloma
  • +2 more
    • Birmingham, Alabama
      Kirklin Clinic of UAB Hospital
    Sep 22, 2022

    Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)

    Not yet recruiting
    • Multiple Myeloma
    • Basking Ridge, New Jersey
    • +6 more
    Sep 22, 2022

    Multiple Myeloma Trial in Tianjin (Anlotinib Hydrochloride Capsule)

    Recruiting
    • Multiple Myeloma
    • Anlotinib Hydrochloride Capsule
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 18, 2022

    Multiple Myeloma, Adapted Physical Activity, Chronic Pain Trial (adapted physical activity)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • adapted physical activity
    • (no location specified)
    Sep 19, 2022

    Malignant Lymphoma, Multiple Myeloma Trial (Pentaisomaltose)

    Not yet recruiting
    • Malignant Lymphoma
    • Multiple Myeloma
    • Pentaisomaltose
    • (no location specified)
    Sep 14, 2022

    Thrombosis in Multiple Myeloma in an University Medical Center

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Multiple myeloma
    • Groningen, Netherlands
      University Medical Center Groningen
    Sep 12, 2022

    Using Mass Spectrometry Detecting Minimal Residual Disease in

    Recruiting
    • Multiple Myeloma
      • Tianjin, China
        InsituteHBDH
      Sep 8, 2022

      Multiple Myeloma Trial in Nashville (Cevostamab, Tocilizumab)

      Recruiting
      • Multiple Myeloma
      • Nashville, Tennessee
        Tennessee Onc., PLLC - SCRI
      Sep 8, 2022

      Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)

      Recruiting
      • Lymphoma
      • Multiple Myeloma
      • Hangzhou, Zhejiang, China
      • +6 more
      Sep 7, 2022

      Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

      Recruiting
      • Lymphoma
      • +3 more
      • Los Angeles, California
      • +48 more
      Aug 19, 2022

      Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

      Recruiting
      • Myelodysplastic Syndrome
      • +4 more
      • Rituximab
      • +6 more
      • Bethesda, Maryland
      • +1 more
      Aug 20, 2022

      Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (CCS1477, Pomalidomide,

      Recruiting
      • Haematological Malignancy
      • +4 more
      • Phoenix, Arizona
      • +14 more
      Aug 22, 2022

      Multiple Myeloma Trial in Germany, United States (TNB-383B)

      Recruiting
      • Multiple Myeloma
      • San Francisco, California
      • +14 more
      Aug 22, 2022

      Multiple Myeloma Trial in Beijing, Nanjing, Tianjin (Isatuximab SAR650984)

      Active, not recruiting
      • Multiple Myeloma
      • Isatuximab SAR650984
      • Beijing, China
      • +2 more
      Aug 22, 2022

      Multiple Myeloma Trial in Worldwide (No intervention)

      Completed
      • Multiple Myeloma
      • No intervention
      • Buenos Aires, Argentina
      • +22 more
      Aug 19, 2022

      Multiple Myeloma Trial in Seoul (Carfilzomib 56 MG [Kyprolis], Pomalidomide, Dexamethasone)

      Recruiting
      • Multiple Myeloma
      • Carfilzomib 56 MG [Kyprolis]
      • +2 more
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Aug 19, 2022

      Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

      Recruiting
      • Multiple Myeloma
      • anti-BCMA/GPRC5D CAR-T CELL
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Aug 19, 2022